{"pmid":32446538,"title":"Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.","text":["Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.","The recent pandemic caused by SARS-CoV-2 has now spread worldwide and caused more than 51,000 deaths, by April 2nd 2020. As predicted, there are several obstacles for medical and governmental authorities to efficiently manage this respiratory illness. In spite of appropriated supplies, most hospitals are suffering from a scarcity of free beds, protective masks, sanitizing liquids and even ECMO machines for patients with severe cases. Defeating this pandemic is impossible without united and coordinated international attempts shaped by all countries of the world. We believe that an international scaled-determination is required to diminish the complex impacts of pandemic. The most important priorities are supposed to be i) The development of potential vaccine candidates to provide protection and interrupt the transmission of SARS-CoV-2, ii) To ensure enough supplies for hospitals and their homogeneous distribution among the countries with the worst number of severe cases, iii) There is a need for more studies to identify potential treatments that are effective for the control of this viral infection and iv) It is imperative to provide easy access to diagnostic kits for all countries affected by this pandemic. In the light of these suggestions, it would be recommendable to at least temporarily abandon the political checkouts in both national and international levels; therefore, all partners will be potentially able to efficiently enforce their strategies for the elimination of this unique threat to the human populations.","Arch Med Res","Perez Perez, Guillermo I","Talebi Bezmin Abadi, Amin","32446538"],"abstract":["The recent pandemic caused by SARS-CoV-2 has now spread worldwide and caused more than 51,000 deaths, by April 2nd 2020. As predicted, there are several obstacles for medical and governmental authorities to efficiently manage this respiratory illness. In spite of appropriated supplies, most hospitals are suffering from a scarcity of free beds, protective masks, sanitizing liquids and even ECMO machines for patients with severe cases. Defeating this pandemic is impossible without united and coordinated international attempts shaped by all countries of the world. We believe that an international scaled-determination is required to diminish the complex impacts of pandemic. The most important priorities are supposed to be i) The development of potential vaccine candidates to provide protection and interrupt the transmission of SARS-CoV-2, ii) To ensure enough supplies for hospitals and their homogeneous distribution among the countries with the worst number of severe cases, iii) There is a need for more studies to identify potential treatments that are effective for the control of this viral infection and iv) It is imperative to provide easy access to diagnostic kits for all countries affected by this pandemic. In the light of these suggestions, it would be recommendable to at least temporarily abandon the political checkouts in both national and international levels; therefore, all partners will be potentially able to efficiently enforce their strategies for the elimination of this unique threat to the human populations."],"journal":"Arch Med Res","authors":["Perez Perez, Guillermo I","Talebi Bezmin Abadi, Amin"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446538","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.arcmed.2020.04.016","keywords":["covid-19","challenge","pandemic","sars-cov-2","who","wuhan"],"topics":["Prevention"],"weight":1,"_version_":1667698385900011521,"score":9.490897,"similar":[{"pmid":32271594,"title":"COVID-19 Pandemic and Comparative Health Policy Learning in Iran.","text":["COVID-19 Pandemic and Comparative Health Policy Learning in Iran.","BACKGROUND: On March 11, 2020, the World Health Organization (WHO) declared the novel coronavirus disease (COVID-19) a global pandemic. Starting in December 2019 from China, the first cases were officially announced on February 19 in Qom city, Iran. As of April 3, 2020, 206 countries have reported a total of 932166 cases with 46764 deaths. Along with China, USA, Italy, Spain, and Germany, Iran has been suffering the hardest burden of COVID-19 outbreak. Worse still, countries like Iran are struggling with the double burden of political sanctions to provide lifesaving medical equipment and medicines to combat the emergency. METHODS: Using systematic document content analysis and through the lenses of health policy triangle, this article aims to compare the policies and strategies that Iran is adopting, with the experience and recommendations of China and WHO to combat COVID-19. RESULTS: Iran has formulated contextual-based policies to combat COVID-19 outbreak before and after virus entrance. Insufficient whole-government, whole-society approach in managing the outbreak, inadequate lifesaving and protective equipment, and delayed decisive governance are the biggest challenges in policy making to combat COVID-19. COVID-19 policies are a public health concern and require professional advocacy attempts through appropriate inter-sectoral collaboration and whole-government coalitions. CONCLUSION: COVID-19 is an unfolding outbreak; hence, policy learning is crucial to formulate appropriate policies and implement them accordingly. Iran has made many efforts to defeat the outbreak, but more coherent, timely and efficient action is required, now, more than ever, to save lives and slow the spread of this pandemic.","Arch Iran Med","Raoofi, Azam","Takian, Amirhossein","Akbari Sari, Ali","Olyaeemanesh, Alireza","Haghighi, Hajar","Aarabi, Mohsen","32271594"],"abstract":["BACKGROUND: On March 11, 2020, the World Health Organization (WHO) declared the novel coronavirus disease (COVID-19) a global pandemic. Starting in December 2019 from China, the first cases were officially announced on February 19 in Qom city, Iran. As of April 3, 2020, 206 countries have reported a total of 932166 cases with 46764 deaths. Along with China, USA, Italy, Spain, and Germany, Iran has been suffering the hardest burden of COVID-19 outbreak. Worse still, countries like Iran are struggling with the double burden of political sanctions to provide lifesaving medical equipment and medicines to combat the emergency. METHODS: Using systematic document content analysis and through the lenses of health policy triangle, this article aims to compare the policies and strategies that Iran is adopting, with the experience and recommendations of China and WHO to combat COVID-19. RESULTS: Iran has formulated contextual-based policies to combat COVID-19 outbreak before and after virus entrance. Insufficient whole-government, whole-society approach in managing the outbreak, inadequate lifesaving and protective equipment, and delayed decisive governance are the biggest challenges in policy making to combat COVID-19. COVID-19 policies are a public health concern and require professional advocacy attempts through appropriate inter-sectoral collaboration and whole-government coalitions. CONCLUSION: COVID-19 is an unfolding outbreak; hence, policy learning is crucial to formulate appropriate policies and implement them accordingly. Iran has made many efforts to defeat the outbreak, but more coherent, timely and efficient action is required, now, more than ever, to save lives and slow the spread of this pandemic."],"journal":"Arch Iran Med","authors":["Raoofi, Azam","Takian, Amirhossein","Akbari Sari, Ali","Olyaeemanesh, Alireza","Haghighi, Hajar","Aarabi, Mohsen"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271594","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.34172/aim.2020.02","keywords":["covid-19","health policy","iran","learning","pandemic"],"locations":["China","Qom","Iran","China","USA","Italy","Spain","Germany","Iran","Iran","Iran","China","Iran","Iran","Iran"],"countries":["Germany","Spain","China","Iran, Islamic Republic of","United States","Italy"],"countries_codes":["DEU|Germany","ESP|Spain","CHN|China","IRN|Iran, Islamic Republic of","USA|United States","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138491763818497,"score":157.3185},{"pmid":32229157,"title":"Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.","text":["Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.","The last month of 2019 harbingered the emergence of a viral outbreak that is now a major public threat globally. COVID-19 was first diagnosed and confirmed in a couple of cases with unknown pneumonia; the patients lived in, or travelled to, Wuhan, the capital of China's Hubei province. People now face a complex challenge that deserves urgent intervention by all involved in medical healthcare globally. Conventional antiviral therapies or vaccines are the most referred means of tackling the virus, but we think establishing these ideal management strategies is presently far-fetched. In-house isolation or quarantine of suspected cases to keep hospital admissions manageable and prevent in-hospital spread of the virus, and promoting general awareness about transmission routes are the practical strategies used to tackle the spread of COVID-19. Cases with weakened or compromised immune systems-for example, elderly individuals, young children, and those with pre-existing conditions such as diabetes, cancer, hypertension, and chronic respiratory diseases-are particularly more susceptible to COVID-19. Hopefully, cumulative data using whole-genome sequencing of the SARS-CoV-2 genome in parallel with mathematical modeling will help the molecular biologists to understand unknown features of the pathogenesis and epidemiology of COVID-19.","Arch Med Res","Rahimi, Farid","Talebi Bezmin Abadi, Amin","32229157"],"abstract":["The last month of 2019 harbingered the emergence of a viral outbreak that is now a major public threat globally. COVID-19 was first diagnosed and confirmed in a couple of cases with unknown pneumonia; the patients lived in, or travelled to, Wuhan, the capital of China's Hubei province. People now face a complex challenge that deserves urgent intervention by all involved in medical healthcare globally. Conventional antiviral therapies or vaccines are the most referred means of tackling the virus, but we think establishing these ideal management strategies is presently far-fetched. In-house isolation or quarantine of suspected cases to keep hospital admissions manageable and prevent in-hospital spread of the virus, and promoting general awareness about transmission routes are the practical strategies used to tackle the spread of COVID-19. Cases with weakened or compromised immune systems-for example, elderly individuals, young children, and those with pre-existing conditions such as diabetes, cancer, hypertension, and chronic respiratory diseases-are particularly more susceptible to COVID-19. Hopefully, cumulative data using whole-genome sequencing of the SARS-CoV-2 genome in parallel with mathematical modeling will help the molecular biologists to understand unknown features of the pathogenesis and epidemiology of COVID-19."],"journal":"Arch Med Res","authors":["Rahimi, Farid","Talebi Bezmin Abadi, Amin"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32229157","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.arcmed.2020.03.005","keywords":["covid-19","coronaviridae","pandemic","prevention","who","wuhan"],"locations":["Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138492171714560,"score":153.49889},{"pmid":32203711,"pmcid":"PMC7102637","title":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.","text":["Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.","WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). The number of patients with COVID-19 infection who might develop severe ARDS that is refractory to maximal medical management and require this level of support is currently unknown. Available evidence from similar patient populations suggests that carefully selected patients with severe ARDS who do not benefit from conventional treatment might be successfully supported with venovenous ECMO. The need for ECMO is relatively low and its use is mostly restricted to specialised centres globally. Providing complex therapies such as ECMO during outbreaks of emerging infectious diseases has unique challenges. Careful planning, judicious resource allocation, and training of personnel to provide complex therapeutic interventions while adhering to strict infection control measures are all crucial components of an ECMO action plan. ECMO can be initiated in specialist centres, or patients can receive ECMO during transportation from a centre that is not specialised for this procedure to an expert ECMO centre. Ensuring that systems enable safe and coordinated movement of critically ill patients, staff, and equipment is important to improve ECMO access. ECMO preparedness for the COVID-19 pandemic is important in view of the high transmission rate of the virus and respiratory-related mortality.","Lancet Respir Med","Ramanathan, Kollengode","Antognini, David","Combes, Alain","Paden, Matthew","Zakhary, Bishoy","Ogino, Mark","MacLaren, Graeme","Brodie, Daniel","Shekar, Kiran","32203711"],"abstract":["WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). The number of patients with COVID-19 infection who might develop severe ARDS that is refractory to maximal medical management and require this level of support is currently unknown. Available evidence from similar patient populations suggests that carefully selected patients with severe ARDS who do not benefit from conventional treatment might be successfully supported with venovenous ECMO. The need for ECMO is relatively low and its use is mostly restricted to specialised centres globally. Providing complex therapies such as ECMO during outbreaks of emerging infectious diseases has unique challenges. Careful planning, judicious resource allocation, and training of personnel to provide complex therapeutic interventions while adhering to strict infection control measures are all crucial components of an ECMO action plan. ECMO can be initiated in specialist centres, or patients can receive ECMO during transportation from a centre that is not specialised for this procedure to an expert ECMO centre. Ensuring that systems enable safe and coordinated movement of critically ill patients, staff, and equipment is important to improve ECMO access. ECMO preparedness for the COVID-19 pandemic is important in view of the high transmission rate of the virus and respiratory-related mortality."],"journal":"Lancet Respir Med","authors":["Ramanathan, Kollengode","Antognini, David","Combes, Alain","Paden, Matthew","Zakhary, Bishoy","Ogino, Mark","MacLaren, Graeme","Brodie, Daniel","Shekar, Kiran"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32203711","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1016/S2213-2600(20)30121-1","topics":["Prevention","Treatment"],"weight":1,"_version_":1666138492411838464,"score":150.90404},{"pmid":32391308,"pmcid":"PMC7193021","title":"COVID-19 Trend Estimation in the Elderly Italian Region of Sardinia.","text":["COVID-19 Trend Estimation in the Elderly Italian Region of Sardinia.","December 2019 saw a novel coronavirus (COVID-19) from China quickly spread globally. Currently, COVID-19, defined as the new pandemic by the World Health Organization (WHO), has reached over 750,000 confirmed cases worldwide. The virus began to spread in Italy from the 22nd February, and the number of related cases is still increasing. Furthermore, given that a relevant proportion of infected people need hospitalization in Intensive Care Units, this may be a crucial issue for National Healthcare System's capacity. WHO underlines the importance of specific disease regional estimates. Because of this, Italy aimed to put in place proportioned and controlled measures, and to guarantee adequate funding to both increase the number of ICU beds and increase production of personal protective equipment. Our aim is to investigate the current COVID-19 epidemiological context in Sardinia region (Italy) and to estimate the transmission parameters using a stochastic model to establish the number of infected, recovered, and deceased people expected. Based on available data from official Italian and regional sources, we describe the distribution of infected cases during the period between 2nd and 15th March 2020. To better reflect the actual spread of COVID-19 in Sardinia based on data from 15th March (first Sardinian declared outbreak), two Susceptible-Infectious-Recovered-Dead (SIRD) models have been developed, describing the best and worst scenarios. We believe that our findings represent a valid contribution to better understand the epidemiological context of COVID-19 in Sardinia. Our analysis can help health authorities and policymakers to address the right interventions to deal with the rapidly expanding health emergency.","Front Public Health","Puci, Mariangela Valentina","Loi, Federica","Ferraro, Ottavia Eleonora","Cappai, Stefano","Rolesu, Sandro","Montomoli, Cristina","32391308"],"abstract":["December 2019 saw a novel coronavirus (COVID-19) from China quickly spread globally. Currently, COVID-19, defined as the new pandemic by the World Health Organization (WHO), has reached over 750,000 confirmed cases worldwide. The virus began to spread in Italy from the 22nd February, and the number of related cases is still increasing. Furthermore, given that a relevant proportion of infected people need hospitalization in Intensive Care Units, this may be a crucial issue for National Healthcare System's capacity. WHO underlines the importance of specific disease regional estimates. Because of this, Italy aimed to put in place proportioned and controlled measures, and to guarantee adequate funding to both increase the number of ICU beds and increase production of personal protective equipment. Our aim is to investigate the current COVID-19 epidemiological context in Sardinia region (Italy) and to estimate the transmission parameters using a stochastic model to establish the number of infected, recovered, and deceased people expected. Based on available data from official Italian and regional sources, we describe the distribution of infected cases during the period between 2nd and 15th March 2020. To better reflect the actual spread of COVID-19 in Sardinia based on data from 15th March (first Sardinian declared outbreak), two Susceptible-Infectious-Recovered-Dead (SIRD) models have been developed, describing the best and worst scenarios. We believe that our findings represent a valid contribution to better understand the epidemiological context of COVID-19 in Sardinia. Our analysis can help health authorities and policymakers to address the right interventions to deal with the rapidly expanding health emergency."],"journal":"Front Public Health","authors":["Puci, Mariangela Valentina","Loi, Federica","Ferraro, Ottavia Eleonora","Cappai, Stefano","Rolesu, Sandro","Montomoli, Cristina"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391308","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3389/fpubh.2020.00153","keywords":["covid-19","sird-model","coronavirus","pandemic","public health emergency"],"locations":["China","Italy","Italy","Sardinia","Italy","Italian","Sardinia","Sardinian","Sardinia","Sardinia"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention","Epidemic Forecasting"],"weight":1,"_version_":1666528580052451329,"score":149.338},{"pmid":32243296,"pmcid":"PMC7173035","title":"The Essential Role of Patient Blood Management in a Pandemic: A Call for Action.","text":["The Essential Role of Patient Blood Management in a Pandemic: A Call for Action.","The World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. Global health care now faces unprecedented challenges with widespread and rapid human-to-human transmission of SARS-CoV-2 and high morbidity and mortality with COVID-19 worldwide. Across the world, the medical care is hampered by a critical shortage of not only hand sanitizers, personal protective equipment, ventilators and hospital beds, but also impediments to the blood supply. Blood donation centers in many areas around the globe have mostly closed. Donors, practicing social distancing, some either with illness or undergoing self-quarantine, are quickly diminishing. Drastic public health initiatives have focused on containment and \"flattening the curve\" while invaluable resources are being depleted. In some countries, the point is reached at which demand for such resources, including donor blood outstrips supply. Questions as to the safety of blood persist. Although it does not appear very likely that the virus can be transmitted through allogeneic blood transfusion, this still remains to be fully determined. As options dwindle, we must enact regional and national shortage plans worldwide, and more vitally disseminate the knowledge of and immediately implement Patient Blood Management (PBM). PBM is an evidence-based bundle of care to optimize medical and surgical patient outcomes by clinically managing and preserving a patient's own blood. This multinational and diverse group of authors issue this \"Call to Action\" underscoring \"The Essential Role of Patient Blood Management in the Management of Pandemics\" and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches.","Anesth Analg","Shander, Aryeh","Goobie, Susan Marie","Warner, Matthew A","Aapro, Matti","Bisbe, Elvira","Perez-Calatayud, Angel A","Callum, Jeannie","Cushing, Melissa M","Dyer, Wayne B","Erhard, Jochen","Faraoni, David","Farmer, Shannon","Fedorova, Tatyana","Frank, Steven M","Froessler, Bernd","Gombotz, Hans","Gross, Irwin","Guinn, Nicole R","Haas, Thorsten","Hamdorf, Jeffrey","Isbister, James P","Javidroozi, Mazyar","Ji, Hongwen","Kim, Young-Woo","Kor, Daryl J","Kurz, Johann","Lasocki, Sigismond","Leahy, Michael F","Lee, Cheuk-Kwong","Lee, Jeong Jae","Louw, Vernon","Meier, Jens","Mezzacasa, Anna","Munoz, Manuel","Ozawa, Sherri","Pavesi, Marco","Shander, Nina","Spahn, Donat R","Spiess, Bruce D","Thomson, Jackie","Trentino, Kevin","Zenger, Christoph","Hofmann, Axel","32243296"],"abstract":["The World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. Global health care now faces unprecedented challenges with widespread and rapid human-to-human transmission of SARS-CoV-2 and high morbidity and mortality with COVID-19 worldwide. Across the world, the medical care is hampered by a critical shortage of not only hand sanitizers, personal protective equipment, ventilators and hospital beds, but also impediments to the blood supply. Blood donation centers in many areas around the globe have mostly closed. Donors, practicing social distancing, some either with illness or undergoing self-quarantine, are quickly diminishing. Drastic public health initiatives have focused on containment and \"flattening the curve\" while invaluable resources are being depleted. In some countries, the point is reached at which demand for such resources, including donor blood outstrips supply. Questions as to the safety of blood persist. Although it does not appear very likely that the virus can be transmitted through allogeneic blood transfusion, this still remains to be fully determined. As options dwindle, we must enact regional and national shortage plans worldwide, and more vitally disseminate the knowledge of and immediately implement Patient Blood Management (PBM). PBM is an evidence-based bundle of care to optimize medical and surgical patient outcomes by clinically managing and preserving a patient's own blood. This multinational and diverse group of authors issue this \"Call to Action\" underscoring \"The Essential Role of Patient Blood Management in the Management of Pandemics\" and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches."],"journal":"Anesth Analg","authors":["Shander, Aryeh","Goobie, Susan Marie","Warner, Matthew A","Aapro, Matti","Bisbe, Elvira","Perez-Calatayud, Angel A","Callum, Jeannie","Cushing, Melissa M","Dyer, Wayne B","Erhard, Jochen","Faraoni, David","Farmer, Shannon","Fedorova, Tatyana","Frank, Steven M","Froessler, Bernd","Gombotz, Hans","Gross, Irwin","Guinn, Nicole R","Haas, Thorsten","Hamdorf, Jeffrey","Isbister, James P","Javidroozi, Mazyar","Ji, Hongwen","Kim, Young-Woo","Kor, Daryl J","Kurz, Johann","Lasocki, Sigismond","Leahy, Michael F","Lee, Cheuk-Kwong","Lee, Jeong Jae","Louw, Vernon","Meier, Jens","Mezzacasa, Anna","Munoz, Manuel","Ozawa, Sherri","Pavesi, Marco","Shander, Nina","Spahn, Donat R","Spiess, Bruce D","Thomson, Jackie","Trentino, Kevin","Zenger, Christoph","Hofmann, Axel"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243296","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1213/ANE.0000000000004844","topics":["Prevention"],"weight":1,"_version_":1666138492137111553,"score":146.50005}]}